Sonoma Pharmaceuticals (SNOA) Assets Average (2011 - 2025)

Sonoma Pharmaceuticals' Assets Average history runs 15 years deep, the most recent figure standing at $13.7 million for Q4 2025.

• In Q4 2025, Assets Average changed 0.46% year-over-year to $13.7 million; the TTM figure through Dec 2025 stood at $13.7 million (changed 0.46% YoY), while the FY2025 annual figure was $14.2 million, down 8.19% from the prior year.
• Assets Average was $13.7 million for Q4 2025 at Sonoma Pharmaceuticals, down from $14.2 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $19.6 million in Q4 2021 to a low of $13.7 million in Q4 2024.
• Historically, Assets Average has averaged $15.4 million across 5 years, with a median of $14.6 million in 2021.
• Biggest YoY gain for Assets Average was 23.69% in 2022; the steepest drop was 26.25% in 2022.
• A 5-year view of Assets Average shows it stood at $19.6 million in 2021, then retreated by 26.25% to $14.4 million in 2022, then retreated by 2.2% to $14.1 million in 2023, then decreased by 3.19% to $13.7 million in 2024, then gained by 0.46% to $13.7 million in 2025.
• The last three Assets Average figures came in at $13.7 million (Q4 2025), $14.2 million (Q3 2025), and $14.1 million (Q2 2025), per Business Quant data.